Although few citizens outside of the livestock industry have heard about this veterinary drug, ractopamine is set to become not only the source of public concern but also the trigger of another endless transatlantic trade dispute. After years of scientific and political deadlock, the Codex...

The establishment of the much-awaited European Food Safety Authority is the most prominent innovation introduced by the recently reformed European regulation of food. Yet, the Authority merely represents one of the components of an entirely new strategy adopted by the European Union in relation...

The government has successfully prosecuted pharmaceutical companies for off-label promotion of drugs, maintaining that such promotion impermissibly undermines the FDA’s pre-market approval process and jeopardizes the public health. In several recent cases, however, pharmaceutical companies...

Once more, while facing an analogous risk phenomenon affecting their predominantly homogeneous societal and economic interests, the US and EU authorities seem to adopt diverging stances. Amid the publication of several new studies and a set of EFSA scientific opinions linking the use of the...

Environmental Law is Becoming More Complex because the executive branch continues to stretch existing environmental laws to accommodate new policies. Without Congressional intervention to craft tailored laws, we run the risk of our environmental administration becoming so complex that it makes...

This volume provides a contextual analysis of EU food law and policy by bringing together for the first time the viewpoints of academics, policymakers, industry representatives as well as those of food practitioners who are exposed daily to this emerging area of study and practice. It is timed...

At a time of increasing recognition worldwide of the role of chief science advisers as of critical importance in improving dialogue between science and policy, the European Union is currently considering – under the pressure of civil society organisations – whether to maintain or scrap this...

Agencies are accustomed to considering questions of discounting — the process that makes monetary amounts comparable through time. But valuing the future is a distinctive enterprise for reasons that go beyond discounting. This Article explores two basic features of time that create challenges...

Controversies over the use and regulation of various technologies pervade public discourse and have serious implications for the public interest. Conflicts over the regulation of genetically modified food, nuclear power, and nanotechnology, among others, fuel some of the most socially and...

Biotechnology has never demonstrated its benefits to society more than in 2021. The SARS-CoV-2 virus that caused the CoVID-19 pandemic met a formidable opponent in mRNA vaccines developed and supplied by Moderna and Pfizer/BioNTech. These vaccines are claimed in myriad – not Myriad – patents...